These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 32503471

  • 1. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
    Silva E, Higgins M, Hammer B, Stephenson P.
    BMC Psychiatry; 2020 Jun 05; 20(1):279. PubMed ID: 32503471
    [Abstract] [Full Text] [Related]

  • 2. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov 05; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 3. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L, Cazard F.
    Encephale; 2016 Aug 05; 42(4):346-53. PubMed ID: 27109327
    [Abstract] [Full Text] [Related]

  • 4. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N, Myles H, Clark SR, Bird R, Siskind D.
    Aust N Z J Psychiatry; 2017 Oct 05; 51(10):980-989. PubMed ID: 28747065
    [Abstract] [Full Text] [Related]

  • 5. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E, Taylor D.
    CNS Drugs; 2007 Oct 05; 21(1):25-35. PubMed ID: 17190527
    [Abstract] [Full Text] [Related]

  • 6. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R, Subhalakshmi TP, Kuruvilla A, Jacob KS.
    J Postgrad Med; 2013 Oct 05; 59(1):54-5. PubMed ID: 23525060
    [Abstract] [Full Text] [Related]

  • 7. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.
    J Clin Psychiatry; 2011 Dec 05; 72(12):1659. PubMed ID: 22244024
    [No Abstract] [Full Text] [Related]

  • 8. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
    Béchard L, Corbeil O, Plante M, Thivierge MA, Lafrenière CÉ, Roy MA, Demers MF.
    J Psychopharmacol; 2021 Sep 05; 35(9):1152-1157. PubMed ID: 34229529
    [Abstract] [Full Text] [Related]

  • 9. Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use.
    Demers MF, Fortier L, Corbeil O, Breault AS, Roy MA.
    Asian J Psychiatr; 2020 Feb 05; 48():101541. PubMed ID: 30314715
    [No Abstract] [Full Text] [Related]

  • 10. Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia.
    Alisky JM.
    Med Hypotheses; 2012 Oct 05; 79(4):497-9. PubMed ID: 22818272
    [Abstract] [Full Text] [Related]

  • 11. Clozapine use in children and adolescents.
    Gogtay N, Rapoport J.
    Expert Opin Pharmacother; 2008 Feb 05; 9(3):459-65. PubMed ID: 18220495
    [Abstract] [Full Text] [Related]

  • 12. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G, Lillo-Le Louet A, Darnige L, Loo H, Krebs MO.
    Encephale; 2013 May 05; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [Abstract] [Full Text] [Related]

  • 13. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I, Bezchlibnyk-Butler K, Wong L.
    Can J Psychiatry; 1996 Jun 05; 41(5):280-4. PubMed ID: 8793147
    [Abstract] [Full Text] [Related]

  • 14. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D.
    Br J Psychiatry; 1996 Oct 05; 169(4):483-8. PubMed ID: 8894200
    [Abstract] [Full Text] [Related]

  • 15. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P, Slater S, Measham T, Koch M, Wiviott G.
    Int Clin Psychopharmacol; 1998 May 05; 13(3):137-40. PubMed ID: 9690982
    [Abstract] [Full Text] [Related]

  • 16. Continuation of Treatment With Clozapine After an Episode of Neutropenia.
    Tirupati S, Gordon T.
    J Clin Psychopharmacol; 1998 May 05; 41(3):320-322. PubMed ID: 33657071
    [Abstract] [Full Text] [Related]

  • 17. Comment on "lithium and clozapine rechallenge: a retrospective case analysis".
    Esposito D.
    J Clin Psychiatry; 2007 Apr 05; 68(4):635; author reply 635. PubMed ID: 17474825
    [No Abstract] [Full Text] [Related]

  • 18. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    BMC Psychiatry; 2016 Dec 12; 16(1):441. PubMed ID: 27955666
    [Abstract] [Full Text] [Related]

  • 19. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
    Dunk LR, Annan LJ, Andrews CD.
    Br J Psychiatry; 2006 Mar 12; 188():255-63. PubMed ID: 16507968
    [Abstract] [Full Text] [Related]

  • 20. A follow-up study of a population of schizophrenic patients treated with clozapine.
    Bourin M, Guitton B, Dailly E, Hery P, Jolliet P.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Nov 12; 25(8):1481-95. PubMed ID: 11642649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.